{"retracted":false,"update":{"timestamp":1485907200000,"doi":"10.1016/j.ygyno.2016.10.034","type":"erratum"},"doi":"10.1016/j.ygyno.2016.02.033","journal":"Gynecologic Oncology","publisher":"Elsevier BV","title":"Corrigendum to ‘Equivalency challenge: evaluation of Lipodox® as the generic equivalent for Doxil® in a human ovarian cancer orthotropic mouse model’ [Gynecol. Oncol. 141 (2016) 357–363]"}
